Brevik EM - Search Results

1

Modifications in dynamic contrast-enhanced magnetic resonance imaging parameters after α-particle-emitting ²²⁷Th-trastuzumab therapy of HER2-expressing ovarian cancer xenografts.

Heyerdahl H, Røe K, Brevik EM, Dahle J. Heyerdahl H, et al. Among authors: brevik em. Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):153-9. doi: 10.1016/j.ijrobp.2013.04.052. Epub 2013 Jun 18. Int J Radiat Oncol Biol Phys. 2013. PMID: 23790511

2

Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts.

Abbas N, Bruland ØS, Brevik EM, Dahle J. Abbas N, et al. Among authors: brevik em. Nucl Med Commun. 2012 Aug;33(8):838-47. doi: 10.1097/MNM.0b013e328354df7c. Nucl Med Commun. 2012. PMID: 22643311

3

Fractionated therapy of HER2-expressing breast and ovarian cancer xenografts in mice with targeted alpha emitting 227Th-DOTA-p-benzyl-trastuzumab.

Heyerdahl H, Abbas N, Brevik EM, Mollatt C, Dahle J. Heyerdahl H, et al. Among authors: brevik em. PLoS One. 2012;7(8):e42345. doi: 10.1371/journal.pone.0042345. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22879947 Free PMC article.

4

Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 positive SKBR-3 xenografts.

Abbas N, Heyerdahl H, Bruland ØS, Brevik EM, Dahle J. Abbas N, et al. Among authors: brevik em. Curr Radiopharm. 2013 Jun 6;6(2):78-86. doi: 10.2174/18744710113069990017. Curr Radiopharm. 2013. PMID: 23551110

5

Microdosimetry modeling with auger emitters in generalized cell geometry.

Palmer TL, Tkacz-Stachowska K, Skartlien R, Omar N, Hassfjell S, Mjøs A, Bergvoll J, Brevik EM, Hjelstuen O. Palmer TL, et al. Among authors: brevik em. Phys Med Biol. 2021 Jun 3;66(11). doi: 10.1088/1361-6560/ac01f5. Phys Med Biol. 2021. PMID: 34081028

6

An efficient chelator for complexation of thorium-227.

Ramdahl T, Bonge-Hansen HT, Ryan OB, Larsen S, Herstad G, Sandberg M, Bjerke RM, Grant D, Brevik EM, Cuthbertson AS. Ramdahl T, et al. Among authors: brevik em. Bioorg Med Chem Lett. 2016 Sep 1;26(17):4318-21. doi: 10.1016/j.bmcl.2016.07.034. Epub 2016 Jul 17. Bioorg Med Chem Lett. 2016. PMID: 27476138 Free article.

7

Organotins in marine mammals and seabirds from Norwegian territory.

Berge JA, Brevik EM, Bjørge A, Følsvik N, Gabrielsen GW, Wolkers H. Berge JA, et al. Among authors: brevik em. J Environ Monit. 2004 Feb;6(2):108-12. doi: 10.1039/b311662j. Epub 2004 Jan 6. J Environ Monit. 2004. PMID: 14760453

8

Solid-phase microextraction coupled with atomic emission spectroscopy--rapid screening for volatile chlorinated compounds.

Semb SI, Pedersen-Bjergaard S, Brevik EM. Semb SI, et al. Among authors: brevik em. Chemosphere. 2002 Dec;49(10):1349-55. doi: 10.1016/s0045-6535(02)00502-7. Chemosphere. 2002. PMID: 12489732

9

Organotin compounds in a Norwegian fjord. A comparison of concentration levels in semipermeable membrane devices (SPMDs), blue mussels (Mytilus edulis) and water samples.

Følsvik N, Brevik EM, Berge JA. Følsvik N, et al. Among authors: brevik em. J Environ Monit. 2002 Apr;4(2):280-3. doi: 10.1039/b111158b. J Environ Monit. 2002. PMID: 11993770

10

Monitoring of organotin compounds in seawater using semipermeable membrane devices (SPMDs)--tentative results.

Følsvik N, Brevik EM, Berge JA. Følsvik N, et al. Among authors: brevik em. J Environ Monit. 2000 Aug;2(4):281-4. doi: 10.1039/b002768p. J Environ Monit. 2000. PMID: 11249780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page